|
1
|
Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells.
|
Cell Stem Cell
|
2007
|
7.05
|
|
2
|
An analogy between the evolution of drug resistance in bacterial communities and malignant tissues.
|
Nat Rev Cancer
|
2011
|
1.58
|
|
3
|
A physical sciences network characterization of non-tumorigenic and metastatic cells.
|
Sci Rep
|
2013
|
1.33
|
|
4
|
Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures.
|
Tissue Eng Part C Methods
|
2010
|
1.04
|
|
5
|
Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis.
|
Cancer Lett
|
2008
|
1.04
|
|
6
|
Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cells.
|
Stem Cell Res Ther
|
2014
|
0.92
|
|
7
|
Autogeneic feeders for the culture of undifferentiated human embryonic stem cells in feeder and feeder-free conditions.
|
Methods Cell Biol
|
2008
|
0.86
|
|
8
|
Distinct regulation of mitogen-activated protein kinase activities is coupled with enhanced cardiac differentiation of human embryonic stem cells.
|
Stem Cell Res
|
2011
|
0.83
|
|
9
|
The time is right: proteome biology of stem cells.
|
Cell Stem Cell
|
2008
|
0.80
|
|
10
|
Time-resolved video analysis and management system for monitoring cardiomyocyte differentiation processes and toxicology assays.
|
Biotechnol J
|
2014
|
0.79
|
|
11
|
Differentiation of human embryonic stem cells to cardiomyocytes on microcarrier cultures.
|
Curr Protoc Stem Cell Biol
|
2012
|
0.79
|
|
12
|
Proteome biology of stem cells: a new joint HUPO and ISSCR initiative.
|
Mol Cell Proteomics
|
2008
|
0.78
|
|
13
|
Proteome biology of stem cells.
|
Stem Cell Res
|
2007
|
0.78
|
|
14
|
Tri-substituted imidazole analogues of SB203580 as inducers for cardiomyogenesis of human embryonic stem cells.
|
Bioorg Med Chem Lett
|
2013
|
0.78
|
|
15
|
The Promise and Therapeutic Potential of Human ES and iPS Cells.
|
Stem Cells Int
|
2011
|
0.77
|
|
16
|
Managing particulates in cellular therapy.
|
Cytotherapy
|
2012
|
0.76
|